drugset / Trial / NCT01340196
Drug Drug Interaction of BI 201335 and Tenofovir
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the drug-drug interaction potential between BI 201335 and concomitantly administered tenofovir which is used in treatment regimens for HIV infection and/or Hepatitis B infection. Results of this study will serve as a basis for guidance of dose adjustments or other precautionary measures when BI201335 and tenofovir are coadministered.
Timeline
- Start
- 2011-04
- Primary completion
- 2011-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Faldaprevir | Small molecule | — | — |
| Subject | Tenofovir | Small molecule | — | — |